Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Ovarian cancer recurrent: Which Medications Are Safest? (106 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

106 medications are used for Ovarian cancer recurrent, with 2,314 combined adverse event reports. The most reported drugs for Ovarian cancer recurrent are NIRAPARIB and OLAPARIB.

2,314
Total Reports
106
Drugs Used

All Medications for Ovarian cancer recurrent Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
NIRAPARIB ZEJULA 521 1,370 4,892 6.3%
OLAPARIB Lynparza 515 5,496 3,471 30.1%
BEVACIZUMAB JOBEVNE 398 17,498 23,114 22.4%
CARBOPLATIN Carboplatin 374 12,544 35,869 14.9%
DOXORUBICIN Doxorubicin Hydrochloride 374 15,653 28,630 18.9%
PACLITAXEL PACLITAXEL PACLITAXEL 250 12,030 31,638 15.6%
TRABECTEDIN YONDELIS 120 376 896 19.2%
GEMCITABINE Gemcitabine 106 5,142 12,268 16.4%
CISPLATIN CISplatin 101 8,387 17,469 17.7%
RUCAPARIB CAMSYLATE Rubraca 101 448 1,148 5.4%
ATEZOLIZUMAB Tecentriq Hybreza 89 8,520 15,094 25.3%
GEMCITABINE\GEMCITABINE - 72 2,206 3,666 21.6%
PEMBROLIZUMAB KEYTRUDA 46 15,543 35,472 18.6%
TOPOTECAN HYCAMTIN 33 773 1,213 21.9%
PEMETREXED Pemetrexed 23 3,876 10,697 16.5%
HYCAMTIN - 20 20 26 37.7%
IRINOTECAN Irinotecan Hydrochloride 20 4,530 10,384 16.2%
LENVATINIB Lenvima 19 4,449 19,975 13.2%
OXALIPLATIN Oxaliplatin 18 6,501 21,980 11.5%
PANITUMUMAB Vectibix 18 1,666 3,121 15.3%

View all 106 drugs →

Most Reported Drugs for Ovarian cancer recurrent

#1 most reported
#2 most reported
#3 most reported